Showing distribution of sensitivity to Semmes-Weinstein monofilament
The repeatability of testing with Semmes-Weinstein monofilaments
Abbreviations: ADL = activity of daily living; AUSCAN = Australian/Canadian Osteoarthritis Hand Index; DASH = Disabilities of the Arm, Shoulder and Hand (questionnaire); GFP = grip force peak; FMLO = grip force at moment of liftoff; MIGF = maximum isometric grip force; MPUT = Moberg Pickup Test; MPUTEC = MPUT with eyes closed; MPUT-EO = MPUT with eyes open; OA = osteoarthritis; PE = percentage error rate; PVEL = peak velocity of instrumented object; SWMT = Semmes-Weinstein Monofilament
Test; VAS = visual analog scale.
Evaluation for peripheral neuropathy was done using 10 g Semmes-Weinstein monofilament
The reproducibility of testing with Semmes-Weinstein monofilaments
Frequency of sensory neuropathy in asymptomatic type 2 diabetic patients using semmes-weinstein monofilament
To include or exclude a patient, we tested for the presence of neuropathy by pressing a 10 g Semmes-Weinstein monofilament
(SWM) (North Coast Medical, Inc; Morgan Hill, California)  three times at each test location (first toe, first metatarsophalangeal joint [MTP1], MTP5, and heel) .
Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament
Measurement of pressure perception threshold using a Semmes-Weinstein monofilament
was highly predictive of future ulceration and amputation.
07 Semmes-Weinstein monofilament
(10g) is sufficient to identify those individuals at risk for ulceration.
OBJECTIVE To evaluate the evidence supporting the Semmes-Weinstein monofilament
(SWM) and other threshold testing in preventing ulcers and amputation.
Decision making in detecting abnormal Semmes-Weinstein monofilament
thresholds in carpal tunnel syndrome.